These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 17292610

  • 41. Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway.
    Fujino T, Murakami K, Ozawa I, Minegishi Y, Kashimura R, Akita T, Saitou S, Atsumi T, Sato T, Ando K, Hara S, Kikugawa K, Hayakawa M.
    FEBS J; 2009 Mar; 276(5):1319-32. PubMed ID: 19187229
    [Abstract] [Full Text] [Related]

  • 42. Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5.
    Pellicciari R, Sato H, Gioiello A, Costantino G, Macchiarulo A, Sadeghpour BM, Giorgi G, Schoonjans K, Auwerx J.
    J Med Chem; 2007 Sep 06; 50(18):4265-8. PubMed ID: 17685603
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. NSAIDs Ibuprofen, Indometacin, and Diclofenac do not interact with Farnesoid X Receptor.
    Schmidt J, Klingler FM, Proschak E, Steinhilber D, Schubert-Zsilavecz M, Merk D.
    Sci Rep; 2015 Oct 01; 5():14782. PubMed ID: 26424593
    [Abstract] [Full Text] [Related]

  • 45. Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators.
    Merk D, Steinhilber D, Schubert-Zsilavecz M.
    Future Med Chem; 2012 May 01; 4(8):1015-36. PubMed ID: 22650242
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Molecular dynamics simulation of the ligand binding domain of farnesoid X receptor. Insights into helix-12 stability and coactivator peptide stabilization in response to agonist binding.
    Costantino G, Entrena-Guadix A, Macchiarulo A, Gioiello A, Pellicciari R.
    J Med Chem; 2005 May 05; 48(9):3251-9. PubMed ID: 15857131
    [Abstract] [Full Text] [Related]

  • 48. Suppression of interleukin-6-induced C-reactive protein expression by FXR agonists.
    Zhang S, Liu Q, Wang J, Harnish DC.
    Biochem Biophys Res Commun; 2009 Feb 06; 379(2):476-9. PubMed ID: 19118524
    [Abstract] [Full Text] [Related]

  • 49. Cytosol-nucleus traffic and colocalization with FXR of conjugated bile acids in rat hepatocytes.
    Monte MJ, Rosales R, Macias RI, Iannota V, Martinez-Fernandez A, Romero MR, Hofmann AF, Marin JJ.
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul 06; 295(1):G54-G62. PubMed ID: 18467501
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists.
    Abel U, Schlüter T, Schulz A, Hambruch E, Steeneck C, Hornberger M, Hoffmann T, Perović-Ottstadt S, Kinzel O, Burnet M, Deuschle U, Kremoser C.
    Bioorg Med Chem Lett; 2010 Aug 15; 20(16):4911-7. PubMed ID: 20638278
    [Abstract] [Full Text] [Related]

  • 54. [Progress in the ligands and their complex structures of farnesoid X receptor].
    Li WH, Fu J, Zheng MY, Liu GX, Tang Y.
    Yao Xue Xue Bao; 2012 Jun 15; 47(6):704-15. PubMed ID: 22919716
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation.
    Soisson SM, Parthasarathy G, Adams AD, Sahoo S, Sitlani A, Sparrow C, Cui J, Becker JW.
    Proc Natl Acad Sci U S A; 2008 Apr 08; 105(14):5337-42. PubMed ID: 18391212
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists.
    Wu X, Glickman JF, Bowen BR, Sills MA.
    J Biomol Screen; 2003 Aug 08; 8(4):381-92. PubMed ID: 14567790
    [Abstract] [Full Text] [Related]

  • 59. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
    Mencarelli A, Renga B, Migliorati M, Cipriani S, Distrutti E, Santucci L, Fiorucci S.
    J Immunol; 2009 Nov 15; 183(10):6657-66. PubMed ID: 19880446
    [Abstract] [Full Text] [Related]

  • 60. Discovery and SAR study of 3-(tert-butyl)-4-hydroxyphenyl benzoate and benzamide derivatives as novel farnesoid X receptor (FXR) antagonists.
    Song K, Xu X, Liu P, Chen L, Shen X, Liu J, Hu L.
    Bioorg Med Chem; 2015 Oct 01; 23(19):6427-36. PubMed ID: 26337021
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.